These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 18301810

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Herbal drug patenting in India: IP potential.
    Sahoo N, Manchikanti P, Dey SH.
    J Ethnopharmacol; 2011 Sep 01; 137(1):289-97. PubMed ID: 21640810
    [Abstract] [Full Text] [Related]

  • 4. Indian pharma enters the global arena.
    Singh S.
    Cell; 2007 Mar 09; 128(5):811-4. PubMed ID: 17350563
    [Abstract] [Full Text] [Related]

  • 5. Overcoming the challenges in the pharma/biotech industry.
    Graul AI, Prous JR.
    Drug News Perspect; 2007 Mar 09; 20(1):57-68. PubMed ID: 17332900
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Are we living in the end of the blockbuster drug era?
    Debnath B, Al-Mawsawi LQ, Neamati N.
    Drug News Perspect; 2010 Dec 09; 23(10):670-84. PubMed ID: 21180653
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Indian biogenerics industry emerges.
    Jayaraman KS.
    Nat Biotechnol; 2003 Oct 09; 21(10):1115-6. PubMed ID: 14520378
    [No Abstract] [Full Text] [Related]

  • 13. Innovation strategies for generic drug companies: moving into supergenerics.
    Ross MS.
    IDrugs; 2010 Apr 09; 13(4):243-7. PubMed ID: 20373253
    [Abstract] [Full Text] [Related]

  • 14. Toxicologic pathology in a multicultural world--India.
    Schultze AE, Reddy VR, Donnelly KB, Berridge BR.
    Toxicol Pathol; 2011 Oct 09; 39(6):1003-9. PubMed ID: 21859882
    [Abstract] [Full Text] [Related]

  • 15. The rise of the generic drug market and its implications for dermatology.
    Bhosle M, Balkrishnan R, Dewan T, Yelverton CB, Feldman SR.
    J Dermatolog Treat; 2005 Oct 09; 16(5-6):295-8. PubMed ID: 16428148
    [Abstract] [Full Text] [Related]

  • 16. Legal challenge to India's patent laws threatens access to generic drugs, says charity.
    Moszynski P.
    BMJ; 2011 Sep 09; 343():d5753. PubMed ID: 21908529
    [No Abstract] [Full Text] [Related]

  • 17. Changes to India's patent law may deny cheap drugs to millions.
    Mudur G.
    BMJ; 2005 Mar 26; 330(7493):692. PubMed ID: 15790640
    [No Abstract] [Full Text] [Related]

  • 18. A vision of the pharmaceutical industry.
    Muñio S.
    Methods Find Exp Clin Pharmacol; 1998 Mar 26; 20 Suppl A():5-9. PubMed ID: 9800720
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Overcoming further challenges in the pharma/biotech industry: 2007 update.
    Graul AI, Cruces E, Revel L, Serradell N, Rosa E.
    Drug News Perspect; 2008 Mar 26; 21(1):44-58. PubMed ID: 18301809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.